Showing results (91-100 of 263) with videos related to
Sort By:
Pageof 27
International Journal of Cancer|November 11, 1992
Variations in the ganglioside profile of uveal melanoma correlate with cytologic heterogeneityS Kanda, A J Cochran, W R Lee, et al.Melanoma Research|October 1, 1993
S-100 protein remains a practical marker for melanocytic and other tumoursA J Cochran, H F Lu, P X Li, et al.Cancer|June 1, 1993
Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thicknessD L Morton, D G Davtyan, L A Wanek, et al.International Journal of Cancer|November 15, 1981
Adjuvant reactivity predicts survival in patients with "high-risk" primary malignant melanoma treated with systemic BCG. EORTC Malignant Melanoma Cooperative Group Writing CommitteeA J Cochran, M E Buyse, F J Lejeune, et al.International Journal of Cancer|September 15, 1976
Leukocyte migration inhibition by cancer patients' seraA J Cochran, R M Mackie, C E Ross, et al.Archives of Dermatology|September 2, 1998
Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastasesR L Barnhill, M W Piepkorn, A J Cochran, et al.Melanoma Research|August 1, 1997
A molecular epidemiological approach to the study of expression of a metastasis marker in primary melanomas and its correlation with individual patient's risk of recurrence or metastasisJ F Doré, P Maisonneuve, M S Cattaruzza, et al.The American Journal of Pediatric Hematology/Oncology|January 1, 1981
Tumor-directed immunity in neuroblastoma patients and their related and unrelated contactsL J Morrison, A J Cochran, G M Baird, et al.The American Journal of Pediatric Hematology/Oncology|January 1, 1982
Tumor-directed immunity in human neuroblastomaL J Morrison, A J Cochran, G M Baird, et al.Clinical and Experimental Immunology|October 1, 1975
Formalinized tumour cells in the leucocyte migration inhibition testC E Ross, A J Cochran, D E Hoyle, et al.Pageof 27